| For items not in this table, use BASIC Mode BASIC Mode Guidelines | |||||
| 1 | Library deployed 08/26/25 15:16 |
||||
| ½ NS - see IV Fluid Plain | |||||
| ½ NS + KCl, KPO4 ( > 500 mL) - see IV Fluid w Lytes | |||||
| 5 | |||||
| 5-FU - see Fluorouracil | |||||
| A | |||||
Abatacept (Orencia) - Conc: 500 mg / 100 mL (5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | |||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Abatacept (Orencia) - Conc: 750 mg / 100 mL (7.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | |||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Abatacept (Orencia) - Conc: 1000 mg / 100 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | |||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Acetylcysteine - Conc: 30 g / 1000 mL (0.03 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 150 mg / kg over 60 min | 151 mg / kg over 60 min | |||
| INFUSION | 15 mg / kg / hr | 15 mg / kg / hr | |||
| Volume to be infused = 1000 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Actemra - see tocilizumab | |||||
| Acyclovir (Zovirax) Adult - Variable conc: 0.5 - 7 mg / mL ✅ | |||||
| Locations: | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 100 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Acyclovir (Zovirax) Peds - Variable conc: 0.5 - 7 mg / mL ✅ | |||||
| Locations: | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 100 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Acyclovir (Zovirax) - Variable conc: 0.5 - 7 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 100 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Acyclovir (Zovirax) - Variable conc: 0.5 - 7 mg / mL ✅ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 100 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Acyclovir (Zovirax) - Variable conc: 2 - 7 mg / mL ✅ | |||||
| Advisory: Dual RN Verification | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mg / kg / hr | 20 mg / kg / hr | 30 mg / kg / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Aggrastat - see tirofiban | |||||
Albumin 25% - mL mode ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 60 mL / hr | 200 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Albumin 25% - mL mode ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 60 mL / hr | 200 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Albumin 5% - Conc: 2.5 g / 50 mL (0.05 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mg / kg / hr | 2000 mg / kg / hr | |||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Alteplase for MI CCU MI ≤67kg - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mg / hr | 100 mg / hr | 100 mg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Alteplase for MI CCU MI >67kg - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 35 mg / hr | 100 mg / hr | 100 mg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Alteplase for MI ED MI ≤67kg - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 15 mg over 2 min | 15 mg over 2 min | |||
| INFUSION | 25 mg / hr | 100 mg / hr | 100 mg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Alteplase for MI ED MI >67kg - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 15 mg over 2 min | 15 mg over 2 min | |||
| INFUSION | 35 mg / hr | 100 mg / hr | 100 mg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Alteplase for PE - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mg / hr | 50 mg / hr | 50 mg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Alteplase for Stroke TPA Stroke <100kg - Conc: 90 mg / 90 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Acute Ischemic Stroke for use in PREGNANT patients ONLY. Dual RN verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 20 mg / hr | 81 mg / hr | 81 mg / hr | ||
| Volume to be infused = 90 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Alteplase for Stroke TPA Stroke ≥100kg - Conc: 90 mg / 90 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Acute Ischemic Stroke for use in PREGNANT patients ONLY. Dual RN verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 81 mg / hr | 81 mg / hr | 81 mg / hr | ||
| Volume to be infused = 90 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Amikacin IVPB - Variable conc: 0.25 - 5 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 550 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Aminocaproic acid Loading Dose - Conc: 1 g / 100 mL (0.01 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 g / hr | 5 g / hr | |||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Aminocaproic acid Maintenance Dose - Conc: 5 g / 250 mL (0.02 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 g / hr | 2 g / hr | 2.5 g / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Aminophylline - Conc: 1000 mg / 1000 mL (1 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.2 mg / kg over 30 min | 5.7 mg / kg over 30 min | |||
| INFUSION | 0.1 mg / kg / hr | 0.6 mg / kg / hr | |||
| Volume to be infused = 1000 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Aminophylline PED - Variable conc: 1 - 1 mg / mL ✅ | |||||
| Advisory: Dual RN Verification | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.05 mg / kg / hr | 1.2 mg / kg / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
AMIODArone Loading Dose - Conc: 150 mg / 100 mL (1.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Use Filter, Monitor QT interval | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2.5 mg / min | 15 mg / min | 30 mg / min | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
AMIODArone Maintenance Dose - Conc: 360 mg / 200 mL (1.8 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Use Filter, Monitor QT interval | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.4 mg / min | 1 mg / min | 2 mg / min | ||
| Volume to be infused = 200 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
AMIODArone Maintenance Dose - Conc: 450 mg / 250 mL (1.8 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mg / min | 1 mg / min | 2 mg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Amphotericin B Liposomal and Lipid - Variable conc: 1 - 2 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Infuse over 2 hours | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 250 mL / hr | |||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Amphotericin B Non-liposomal/lipid - Variable conc: 0.02 - 0.1 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Infuse over 4-6 hours | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 62.5 mL / hr | 125 mL / hr | |||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Ampicillin IVPB - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ampicillin IVPB - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ampicillin IVPB - Conc: 2 g / 100 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ampicillin IVPB - Conc: 2 g / 100 mL (0.02 g / mL) ✅ | |||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ampicillin-Sulb IVPB - Conc: 1.5 g / 50 mL (0.03 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ampicillin-Sulb IVPB - Conc: 3 g / 100 mL (0.03 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ampicillin-Sulb IVPB - Conc: 9 g / 250 mL (0.036 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 500 mL / hr | 550 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ancef - see ceFAZolin | |||||
| Angiomax - see bivalirudin | |||||
| Anidulafungin-Eraxis - Conc: 50 mg / 65 mL (0.769 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 60 mL / hr | 65 mL / hr | 84 mL / hr | ||
| Volume to be infused = 65 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Anidulafungin-Eraxis - Conc: 100 mg / 130 mL (0.769 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 39 mL / hr | 78 mL / hr | 84 mL / hr | ||
| Volume to be infused = 130 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Anidulafungin-Eraxis - Conc: 200 mg / 260 mL (0.769 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 39 mL / hr | 78 mL / hr | 84 mL / hr | ||
| Volume to be infused = 260 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Antivenin-Crotalidae - Variable conc: 0.004 - 0.032 g / mL ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 25 mL over 10 min | 25 mL over 10 min | 50 mL over 10 min | ||
| INFUSION | 200 mL / hr | 250 mL / hr | 275 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Aredia - see pamidronate | |||||
Argatroban - Conc: 50 mg / 50 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.15 mcg / kg / min | 10 mcg / kg / min | |||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ativan - see LORazepam | |||||
| Avelox - see moxifloxacin | |||||
| Avycaz - see cefTAZidime-avibactam | |||||
| Azithromycin IVPB - Conc: 500 mg / 250 mL (2 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, Ped > 20 kg, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 250 mL / hr | 275 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Azithromycin IVPB - Variable conc: 0.01 - 2 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, Ped > 20 kg, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 250 mL / hr | 275 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Aztreonam (Azactam) - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Aztreonam (Azactam) - Conc: 2 g / 100 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| B | |||||
| Bactrim (SMZ-TMP) - mL mode ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 75 mL / hr | 250 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Banana Bag - see Rally Bag | |||||
| BASIC Mode - see BASIC Mode Guidelines | |||||
| Belatacept (Nulojix) - Variable conc: 2 - 10 mg / mL ✅ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 205 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Bezlotoxumab - Variable conc: 1 - 10 mg / mL ❌ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Bivalirudin-AngioMax - Conc: 250 mg / 50 mL (5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.2 mg / kg over 5 min | 0.75 mg / kg over 5 min | |||
| LOAD | 0.2 mg / kg over 5 min | 0.75 mg / kg over 5 min | |||
| INFUSION | 0.2 mg / kg / hr | 1.75 mg / kg / hr | 1.76 mg / kg / hr | 2.5 mg / kg / hr | |
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Blood FFP - mL mode ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 60 mL / hr | 600 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Blood FFP - mL mode ✅ | |||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 60 mL / hr | 600 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Blood Platelets - mL mode ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 60 mL / hr | 1000 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Blood Platelets - mL mode ✅ | |||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 60 mL / hr | 120 mL / hr | 1000 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 1 mL/hr) | |||||
| Blood RBC - mL mode ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 500 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Blood RBC - mL mode ✅ | |||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 120 mL / hr | 500 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 1 mL/hr) | |||||
| Brevibloc - see esmolol | |||||
| C | |||||
| Caffeine Na Benzoate - Conc: 500 mg / 1000 mL (0.5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 1000 mL / hr | |||
| Volume to be infused = 1000 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Calcium Gluconate - Conc: 1 g / 50 mL (0.02 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Calcium Gluconate - Conc: 2 g / 100 mL (0.02 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Calcium Gluconate - Conc: 3 g / 100 mL (0.03 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 33.3 mL / hr | 33.3 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cancidas - see caspofungin | |||||
CARBOplatin - Variable conc: 0.1 - 2.88 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 500 mL / hr | 505 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Cardene - see niCARdipine | |||||
| Cardizem - see diltiaZEM | |||||
| Carnitor - see levOCARNitine | |||||
| Casirivimab-Imdevima - Conc: 1200 mg / 100 mL (12 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 300 mL / hr | 310 mL / hr | 320 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Caspofungin - Variable conc: 0.1 - 0.2 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Do NOT administer with Dextrose | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 250 mL / hr | |||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Cefazolin IVPB Dose ≤1g - Conc: 250 mg / 50 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefazolin IVPB Dose ≤1g - Conc: 500 mg / 50 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefazolin IVPB Dose ≤1g - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefazolin IVPB Dose ≥ 2g - Conc: 2 g / 50 mL (0.04 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefazolin IVPB Dose ≥ 2g - Conc: 2 g / 100 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefazolin IVPB Dose ≥ 2g - Conc: 3 g / 100 mL (0.03 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefepime IVPB - Conc: 250 mg / 50 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefepime IVPB - Conc: 500 mg / 50 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefepime IVPB - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefepime IVPB - Conc: 2 g / 50 mL (0.04 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefiderocol-Fetroja - Conc: 750 mg / 100 mL (7.5 mg / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 15 mL / hr | 33.3 mL / hr | 33.5 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefiderocol-Fetroja - Conc: 1 g / 100 mL (0.01 g / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 15 mL / hr | 33.3 mL / hr | 33.5 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefiderocol-Fetroja - Conc: 1.5 g / 100 mL (0.015 g / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 15 mL / hr | 33.3 mL / hr | 33.5 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefiderocol-Fetroja - Conc: 2 g / 100 mL (0.02 g / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 15 mL / hr | 33.3 mL / hr | 33.5 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| cefotaxime- Claforan - Conc: 500 mg / 50 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| cefotaxime- Claforan - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| cefotaxime- Claforan - Conc: 2 g / 50 mL (0.04 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefoxitin (Mefoxin) - Conc: 500 mg / 50 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 100 mL / hr | 105 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefoxitin (Mefoxin) - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefoxitin (Mefoxin) - Conc: 2 g / 100 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftaroline- Teflaro - Conc: 200 mg / 50 mL (4 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftaroline- Teflaro - Conc: 300 mg / 50 mL (6 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftaroline- Teflaro - Conc: 400 mg / 50 mL (8 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 8 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftaroline- Teflaro - Conc: 600 mg / 50 mL (12 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftazidime (Fortaz) - Conc: 1 g / 100 mL (0.01 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftazidime (Fortaz) - Conc: 2 g / 100 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 200 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftazidime-Avibact. - Conc: 0.94 g / 50 mL (0.019 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 15 mL / hr | 25 mL / hr | 28 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftazidime-Avibact. - Conc: 1.25 g / 100 mL (0.013 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftazidime-Avibact. - Conc: 2.5 g / 100 mL (0.025 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftolozane-Tazobact - Conc: 375 mg / 100 mL (3.75 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftolozane-Tazobact - Conc: 750 mg / 100 mL (7.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftolozane-Tazobact - Conc: 1.5 g / 100 mL (0.015 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ceftolozane-Tazobact - Conc: 3 g / 100 mL (0.03 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftriaxone IVPB - Conc: 500 mg / 50 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 100 mL / hr | 105 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftriaxone IVPB - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ceftriaxone IVPB - Conc: 2 g / 50 mL (0.04 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefuroxime (Zinacef) - Conc: 750 mg / 100 mL (7.5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cefuroxime (Zinacef) - Conc: 1.5 g / 100 mL (0.015 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cerebyx - see fosphenytoin | |||||
| Chlorothiazide IVPB - Conc: 500 mg / 50 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Cidofovir (Vistide) - Variable conc: 0.01 - 3.75 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ciprofloxacin - Conc: 200 mg / 100 mL (2 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 105 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ciprofloxacin - Conc: 400 mg / 200 mL (2 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 200 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Cisatracurium-Nimbex - Conc: 100 mg / 250 mL (0.4 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.1 mcg / kg / min | 1 mcg / kg / min | 10 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Cisplatin Dose ≤ 50 mg - Variable conc: 0.004 - 0.2 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 500 mL / hr | 550 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Cisplatin Dose > 50 mg - Variable conc: 0.1 - 0.2 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 500 mL / hr | 550 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Claforan - see cefotaxime | |||||
| Cleocin - see clindamycin | |||||
| Clindamycin - Conc: 300 mg / 50 mL (6 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Clindamycin - Conc: 600 mg / 50 mL (12 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Clindamycin - Conc: 900 mg / 50 mL (18 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Clinimix TPN Central Line - mL mode ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 175 mL / hr | |||
| Volume to be infused = 1000 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Clinimix TPN Peripheral 2.75/5 E - mL mode ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 175 mL / hr | |||
| Volume to be infused = 1000 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Corlopam - see fenoldopam | |||||
| Corvert - see ibutilide | |||||
| Cubicin - see DAPTOmycin | |||||
Cyclosporine-Sandim. - Variable conc: 0.04 - 2.5 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 31 mL / hr | 62.5 mL / hr | 63 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Cytarabin(Cytosar-U) - Variable conc: 0.04 - 5 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 510 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Cytovene - see ganciclovir | |||||
| D | |||||
| D5… - see IV Fluid Plain | |||||
| D5… + KCl, KPO4 ( > 500 mL) - see IV Fluid w Lytes | |||||
| Dacogen - see decitabine | |||||
| Dalbavancin-Dalvance - Conc: 1500 mg / 500 mL (3 mg / mL) ❌ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 500 mL / hr | 1000 mL / hr | 1100 mL / hr | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Dalbavancin-Dalvance - Variable conc: 1 - 5 mg / mL ❌ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 500 mL / hr | 510 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Daptomycin (Cubicin) - Conc: 350 mg / 50 mL (7 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Daptomycin (Cubicin) - Conc: 500 mg / 50 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Daptomycin (Cubicin) - Conc: 700 mg / 100 mL (7 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Daptomycin (Cubicin) - Conc: 1000 mg / 100 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| DDAVP - see desmopressin | |||||
| Decadron - see dexamethosone | |||||
Decitabine (Dacogen) - Variable conc: 0.1 - 1 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 40 mL / hr | 83.3 mL / hr | 84 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Deferoxamine - Conc: 2000 mg / 500 mL (4 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), CCU, ED, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 75 mL / hr | 125 mL / hr | 137 mL / hr | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Depacon - see valproic acid | |||||
| Desferal - see deferoxamine | |||||
| Desmopressin - Conc: 12.5 mcg / 250 mL (0.05 mcg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 500 mL / hr | 550 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Desmopressin - Variable conc: 0.07 - 0.37 mcg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Dexamethasone - Conc: 10 mg / 50 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Dexmedetomidine CC&ED Extended HM - Conc: 200 mcg / 50 mL (4 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.1 mcg / kg over 10 min | 0.1 mcg / kg over 10 min | |||
| INFUSION | 0.2 mcg / kg / hr | 0.4 mcg / kg / hr | 0.7 mcg / kg / hr | 2.5 mcg / kg / hr | |
| dexmedetomidine is a "Care Area Critical Med": Hard MAX = 2.5 mcg/kg/hr Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Dexmedetomidine CC&ED Extended HM - Conc: 400 mcg / 100 mL (4 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.1 mcg / kg over 10 min | 0.1 mcg / kg over 10 min | |||
| INFUSION | 0.2 mcg / kg / hr | 0.4 mcg / kg / hr | 0.7 mcg / kg / hr | 2.5 mcg / kg / hr | |
| dexmedetomidine is a "Care Area Critical Med": Hard MAX = 2.5 mcg/kg/hr Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Dexmedetomidine CC&ED Low Max Infus. - Conc: 200 mcg / 50 mL (4 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.1 mcg / kg over 10 min | 0.1 mcg / kg over 10 min | |||
| INFUSION | 0.2 mcg / kg / hr | 0.7 mcg / kg / hr | 1.4 mcg / kg / hr | ||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Dexmedetomidine CC&ED Low Max Infus. - Conc: 400 mcg / 100 mL (4 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.1 mcg / kg over 10 min | 0.1 mcg / kg over 10 min | |||
| INFUSION | 0.2 mcg / kg / hr | 0.7 mcg / kg / hr | 1.4 mcg / kg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Dexmedetomidine - Conc: 200 mcg / 50 mL (4 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.1 mcg / kg over 10 min | 0.1 mcg / kg over 10 min | |||
| INFUSION | 0.2 mcg / kg / hr | 0.7 mcg / kg / hr | 1.4 mcg / kg / hr | ||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Dexmedetomidine - Conc: 400 mcg / 100 mL (4 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.1 mcg / kg over 10 min | 0.1 mcg / kg over 10 min | |||
| INFUSION | 0.2 mcg / kg / hr | 0.7 mcg / kg / hr | 1.4 mcg / kg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Dextrose 10% - mL mode ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 125 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Dextrose 10% - mL mode ✅ | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mL / hr | 125 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Dextrose 10% - mL mode ✅ | |||||
| Locations: SCN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mL / hr | 15 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Diflucan - see fluconazole | |||||
| Digibind - see digoxin immune FAB | |||||
Digoxin Immune FAB - Conc: 400 mg / 50 mL (8 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Dilantin - see phenytoin | |||||
| Dilaudid - see HYDROmorphone | |||||
Diltiazem Cardizem - Conc: 125 mg / 125 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mg / hr | 5 mg / hr | 15 mg / hr | ||
| Volume to be infused = 125 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Diprivan - see propofol | |||||
| Diuril - see chlorothiazide | |||||
DOBUTamine - Conc: 250 mg / 250 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
DOBUTamine - Conc: 250 mg / 250 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
DOBUTamine - Conc: 500 mg / 250 mL (2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
DOBUTamine - Conc: 500 mg / 250 mL (2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Docetaxel (Taxotere) Dose ≤ 184mg - Variable conc: 0.3 - 0.74 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Docetaxel (Taxotere) Dose ≥ 185 mg - Variable conc: 0.3 - 0.74 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 500 mL / hr | 500 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
DOPamine Double Concentration - Conc: 800 mg / 250 mL (3.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
DOPamine Double Concentration - Conc: 800 mg / 250 mL (3.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
DOPamine Single Concentration - Conc: 400 mg / 250 mL (1.6 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
DOPamine Single Concentration - Conc: 400 mg / 250 mL (1.6 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
DOPamine Single Concentration - Conc: 800 mg / 500 mL (1.6 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
DOPamine Single Concentration - Conc: 800 mg / 500 mL (1.6 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / kg / min | 2 mcg / kg / min | 20 mcg / kg / min | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Doxycycline IVPB - Conc: 100 mg / 100 mL (1 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Doxycycline IVPB - Conc: 200 mg / 100 mL (2 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| E | |||||
| Elitek - see rasburicase | |||||
| Eloxatin - see OXALIplatin | |||||
| Emend - see fosaprepitant | |||||
| EPInephrine - Conc: 1 mg / 250 mL (0.004 mg / mL) | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / min | 2 mcg / min | 80 mcg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
EPInephrine - Conc: 4 mg / 250 mL (0.016 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / min | 2 mcg / min | 160 mcg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 1 mL/hr) | |||||
EPInephrine - Conc: 4 mg / 250 mL (0.016 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / min | 2 mcg / min | 160 mcg / min | ||
| EPINEPHrine is a "Care Area Critical Med": Hard MAX = 160 mcg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Eptinezumab(Vyepti) - Conc: 100 mg / 100 mL (1 mg / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Eptinezumab(Vyepti) - Conc: 300 mg / 100 mL (3 mg / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Eraxis - see anidulafungin | |||||
Ertapenem (Invanz) - Conc: 500 mg / 50 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ertapenem (Invanz) - Conc: 1 g / 50 mL (0.02 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Erythromycin - Conc: 500 mg / 100 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Erythromycin - Conc: 1 g / 250 mL (0.004 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Esmolol (Brevibloc) - Conc: 2500 mg / 250 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 500 mcg / kg over 1 min | 1000 mcg / kg over 5 min | 1000 mcg / kg over 5 min | ||
| LOAD | 500 mcg / kg over 1 min | 1000 mcg / kg over 5 min | 1000 mcg / kg over 5 min | ||
| INFUSION | 5 mcg / kg / min | 50 mcg / kg / min | 200 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Esmolol (Brevibloc) - Variable conc: 5 - 10 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 500 mcg / kg over 1 min | 1000 mcg / kg over 5 min | 1000 mcg / kg over 5 min | ||
| LOAD | 500 mcg / kg over 1 min | 1000 mcg / kg over 5 min | 1000 mcg / kg over 5 min | ||
| INFUSION | 5 mcg / kg / min | 50 mcg / kg / min | 200 mcg / kg / min | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Etoposide (Vepesid) - Variable conc: 0.2 - 0.4 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 1000 mL / hr | |||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| F | |||||
| Famotidine (Pepcid) - Conc: 20 mg / 100 mL (0.2 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Fentanyl CC&ED Extended HM - Conc: 1000 mcg / 120 mL (8.33 mcg / mL) | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 4.2 mcg / hr | 800 mcg / hr | |||
| Volume to be infused = 120 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Fentanyl CC&ED Extended HM - Conc: 2500 mcg / 300 mL (8.33 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 4.2 mcg / hr | 25 mcg / hr | 800 mcg / hr | ||
| fentaNYL is a "Care Area Critical Med": Hard MAX = 800 mcg/hr Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 300 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Fentanyl CC&ED Low Max Infus. - Conc: 1000 mcg / 120 mL (8.33 mcg / mL) | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 4.2 mcg / hr | 800 mcg / hr | |||
| Volume to be infused = 120 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Fentanyl CC&ED Low Max Infus. - Conc: 2500 mcg / 300 mL (8.33 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 4.2 mcg / hr | 25 mcg / hr | 300 mcg / hr | ||
| Volume to be infused = 300 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Fentanyl - Conc: 1000 mcg / 120 mL (8.33 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 4.2 mcg / hr | 25 mcg / hr | 300 mcg / hr | ||
| Volume to be infused = 120 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Fentanyl - Conc: 2500 mcg / 300 mL (8.33 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 4.2 mcg / hr | 25 mcg / hr | 300 mcg / hr | ||
| Volume to be infused = 300 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Ferric carboxymalto. Dose <750mg - Variable conc: 2 - 3 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 500 mL / hr | 1000 mL / hr | 1100 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ferric carboxymalto. Dose =750mg - Conc: 750 mg / 250 mL (3 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 500 mL / hr | 1000 mL / hr | 1100 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| ferric gluconate - see Ferrlecit | |||||
| Ferrlecit - Conc: 62.5 mg / 50 mL (1.25 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 12 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ferrlecit - Conc: 62.5 mg / 50 mL (1.25 mg / mL) ✅ | |||||
| Advisory: Dual RN Verification | |||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 12 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ferrlecit - Conc: 125 mg / 100 mL (1.25 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 12 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ferrlecit - Conc: 125 mg / 100 mL (1.25 mg / mL) ✅ | |||||
| Advisory: Dual RN Verification | |||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 12 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Ferrlecit - Conc: 250 mg / 100 mL (2.5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 6 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Fetroja - see cefiderocol | |||||
| FFP - see Blood FFP | |||||
| Flagyl - see metroNIDAZOLE | |||||
Fluconazole - Conc: 100 mg / 50 mL (2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Fluconazole - Conc: 200 mg / 100 mL (2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Fluconazole - Conc: 400 mg / 200 mL (2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 200 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Fluorouracil (5-FU) - Variable conc: 0.2 - 10 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 150 mL / hr | 155 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Folic Acid - Conc: 1 mg / 50 mL (0.02 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Fortaz - see cefTAZidime | |||||
| Fosaprepitant - Conc: 150 mg / 150 mL (1 mg / mL) ✅ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 300 mL / hr | 435 mL / hr | ||
| Volume to be infused = 150 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Foscarnet (Foscavir) Dose ≤ 3000 mg - Variable conc: 2 - 12 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 125 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Foscarnet (Foscavir) Dose > 3000 mg - Variable conc: 2 - 12 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Fosphenytoin - Variable conc: 1.5 - 25 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Furosemide IVPB - Conc: 100 mg / 50 mL (2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 120 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Furosemide IVPB - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 100 mL / hr | 240 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| G | |||||
Ganciclovir-Cytovene - Variable conc: 0.5 - 10 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Gentamicin IVPB - Variable conc: 0.6 - 10 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Glucagon - Conc: 4 mg / 50 mL (0.08 mg / mL) ✅ | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mL / hr | 20 mL / hr | |||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Glucagon - Conc: 25 mg / 250 mL (0.1 mg / mL) ✅ | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mL / hr | 20 mL / hr | |||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| H | |||||
Heparin Adult IV - Conc: 25000 Units / 250 mL (100 Units / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 500 Units / hr | 2500 Units / hr | 3500 Units / hr | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Heparin Peds IV - Conc: 25000 Units / 250 mL (100 Units / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2 Units / kg / hr | 25 Units / kg / hr | 60 Units / kg / hr | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Heparin Peds IV - Variable conc: 50 - 100 Units / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2 Units / kg / hr | 25 Units / kg / hr | 60 Units / kg / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Herceptin - see trastuzumab | |||||
Hydromorphone - Conc: 40 mg / 80 mL (0.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.25 mg / hr | 4 mg / hr | 8 mg / hr | ||
| Volume to be infused = 80 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Hydromorphone - Variable conc: 0.25 - 0.5 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.25 mg / hr | 4 mg / hr | 8 mg / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Hypertonic Saline - see Sodium Chloride 3% | |||||
| I | |||||
Ibutilide (Corvert) Weight <60kg - Variable conc: 0.007 - 0.011 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Infuse Over 10 minutes <60 kg | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 300 mL / hr | 336 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Ibutilide (Corvert) Weight ≥ 60kg - Conc: 1 mg / 60 mL (0.017 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 300 mL / hr | 360 mL / hr | 360 mL / hr | ||
| Volume to be infused = 60 mL, secondary only, (KVO rate = 1 mL/hr) | |||||
| Imdevima - see casirivimab | |||||
| Imipenem/Cilastatin - Conc: 500 mg / 100 mL (5 mg / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Immune Globulin 10% - Conc: 5 g / 50 mL (0.1 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mg / kg / min | 8 mg / kg / min | |||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Immune Globulin 10% - Conc: 10 g / 100 mL (0.1 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mg / kg / min | 8 mg / kg / min | |||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Immune Globulin 10% - Conc: 20 g / 200 mL (0.1 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mg / kg / min | 8 mg / kg / min | |||
| Volume to be infused = 200 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Infed - see iron dextran | |||||
| Injectafer - see ferric carboxymalto | |||||
Insulin Adult Insulin Drip - Conc: 100 Units / 100 mL (1 Units / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 Units over 3 min | 12 Units over 3 min | |||
| LOAD | 0.5 Units over 3 min | 12 Units over 3 min | |||
| INFUSION | 0.5 Units / hr | 12 Units / hr | 40 Units / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Insulin Adult Insulin Over 10 mins - Variable conc: 0.02 - 0.2 Units / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 300 mL / hr | 300 mL / hr | ||
| Undefined volume to be infused, secondary only, (KVO rate = 1 mL/hr) | |||||
Insulin Adult - Variable conc: 0.02 - 0.2 Units / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 300 mL / hr | 300 mL / hr | ||
| Undefined volume to be infused, secondary only, (KVO rate = 1 mL/hr) | |||||
Insulin Peds - Variable conc: 0.5 - 1 Units / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: PED ≤ 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 Units over 1 min | 3.33 Units over 1 min | |||
| LOAD | 0.5 Units over 1 min | 3.33 Units over 1 min | |||
| INFUSION | 0.01 Units / hr | 0.1 Units / hr | 0.5 Units / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Insulin Peds - Variable conc: 0.5 - 1 Units / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 Units over 1 min | 3.33 Units over 1 min | |||
| LOAD | 0.5 Units over 1 min | 3.33 Units over 1 min | |||
| INFUSION | 0.01 Units / hr | 0.1 Units / hr | 0.5 Units / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Intralipid - see lipids | |||||
| Intropin - see DOPamine | |||||
| INVanz - see Ertapenem | |||||
Iron Dextran - Variable conc: 0.2 - 1 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 175 mL / hr | 175 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Isoproterenol - Conc: 2 mg / 250 mL (0.008 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2 mcg / min | 10 mcg / min | |||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| IV Fluid Plain - mL mode ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, IPN, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 250 mL over 60 min | 999 mL over 60 min | |||
| INFUSION | 10 mL / hr | 150 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| IV Fluid Plain - mL mode ✅ | |||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 250 mL over 10 min | 999 mL over 60 min | |||
| INFUSION | 10 mL / hr | 500 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 1 mL/hr) | |||||
| IV Fluid Plain - mL mode ✅ | |||||
| Locations: PED ≤ 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 3 mL / hr | 150 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| IV Fluid Plain - mL mode ✅ | |||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 3 mL / hr | 250 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| IV Fluid Plain - mL mode ✅ | |||||
| Locations: SCN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 15 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| IV Fluid w Lytes - mL mode ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 250 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| IV Fluid w Lytes - mL mode ✅ | |||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 250 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 1 mL/hr) | |||||
| IV Fluid w Lytes - mL mode ✅ | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 3 mL / hr | 100 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| IV Fluid w Lytes - mL mode ✅ | |||||
| Locations: SCN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 250 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| K | |||||
Kcentra Weight <70 Kg - Variable conc: 5 - 25.1 Units / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Do not allow blood to enter in syringe or clot may occur | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mL / kg / min | 3 mL / kg / min | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Kcentra Weight ≥70 Kg - Variable conc: 5 - 25.1 Units / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Do not allow blood to enter in syringe or clot may occur | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 450 mL / hr | 500 mL / hr | 501 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
KCL Pediatric - Variable conc: 0.005 - 0.01 mEq / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.02 mEq / kg / hr | 0.5 mEq / kg / hr | 0.5 mEq / kg / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| KCl premixes (1,000 mL) - see IV Fluid w Lytes | |||||
KCL Rider Central Line - Conc: 10 mEq / 100 mL (0.1 mEq / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: If >10mEq/hr required Cardiac monitoring | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2 mL / hr | 100 mL / hr | 200 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
KCL Rider Central Line + TELE - Conc: 20 mEq / 100 mL (0.2 mEq / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 100 mL, secondary only, (KVO rate = 1 mL/hr) | |||||
KCL Rider Peripheral Line - Conc: 10 mEq / 100 mL (0.1 mEq / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Keppra - see levETIRAcetam | |||||
Ketamine CC&ED Extended HM - Conc: 500 mg / 500 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 5 min | 1 mg over 5 min | 1.25 mg over 5 min | ||
| INFUSION | 0.1 mg / kg / hr | 1.2 mg / kg / hr | 4 mg / kg / hr | ||
| ketamine is a "Care Area Critical Med": Hard MAX = 4 mg/kg/hr Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 500 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Ketamine CC&ED Low Max Infus. - Conc: 500 mg / 500 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 5 min | 1 mg over 5 min | 1.25 mg over 5 min | ||
| INFUSION | 0.1 mg / kg / hr | 1.2 mg / kg / hr | 2.5 mg / kg / hr | ||
| Volume to be infused = 500 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Ketamine - Conc: 500 mg / 500 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 5 min | 1 mg over 5 min | 1.25 mg over 5 min | ||
| INFUSION | 0.1 mg / kg / hr | 1.2 mg / kg / hr | 2.5 mg / kg / hr | ||
| Volume to be infused = 500 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Kevzara - see sarilumab | |||||
| Keytruda - see pembrolizumab | |||||
| L | |||||
Labetalol (Trandate) - Conc: 200 mg / 200 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mg / min | 1 mg / min | 2 mg / min | 3 mg / min | |
| Volume to be infused = 200 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Lacosamide (Vimpat) - Conc: 50 mg / 50 mL (1 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Lacosamide (Vimpat) - Conc: 100 mg / 50 mL (2 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Lacosamide (Vimpat) - Conc: 200 mg / 70 mL (2.86 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 35 mL / hr | 70 mL / hr | 70 mL / hr | ||
| Volume to be infused = 70 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Lactated Ringers - see IV Fluid Plain | |||||
| Lactated Ringers + KCl, KPO4 ( > 500 mL) - see IV Fluid w Lytes | |||||
| Leucovorin - Variable conc: 0.02 - 0.7 mg / mL ✅ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 200 mL / hr | 250 mL / hr | 251 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Levetiracetam-Keppra Dose ≤1500mg - Conc: 250 mg / 100 mL (2.5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 400 mL / hr | 405 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levetiracetam-Keppra Dose ≤1500mg - Conc: 500 mg / 100 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levetiracetam-Keppra Dose ≤1500mg - Conc: 1000 mg / 100 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levetiracetam-Keppra Dose ≤1500mg - Conc: 1500 mg / 100 mL (15 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levetiracetam-Keppra Dose >1500 mg - Variable conc: 0.04 - 45 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levocarnitine - Variable conc: 0.5 - 8 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 500 mL / hr | 1000 mL / hr | 1000 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levofloxacin - Conc: 250 mg / 50 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levofloxacin - Conc: 500 mg / 100 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levofloxacin - Conc: 750 mg / 150 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 150 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Levophed - see norEPINEPHrine | |||||
| Levothyroxine - Conc: 200 mcg / 500 mL (0.4 mcg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 20 mL / hr | 25 mL / hr | 50 mL / hr | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Lidocaine - Conc: 2000 mg / 500 mL (4 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.1 mg / min | 4 mg / min | |||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Lidocaine - Variable conc: 2 - 4.1 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.1 mg / min | 4 mg / min | |||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Linezolid (Zyvox) - Conc: 600 mg / 300 mL (2 mg / mL) ✅ | |||||
| Advisory: FLUSH IV LINE W/ NS OR D5W BEFORE AND AFTER ADMINISTRATION. | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 300 mL / hr | 310 mL / hr | ||
| Volume to be infused = 300 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Lipids - mL mode ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mL / hr | 125 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Lorazepam (Ativan) - Conc: 20 mg / 100 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.1 mg over 1 min | 2 mg over 1 min | 2 mg over 1 min | ||
| INFUSION | 0.1 mg / hr | 5 mg / hr | |||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Lorazepam (Ativan) - Conc: 20 mg / 100 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Use Filter | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 1 min | 2 mg over 3 min | 2 mg over 3 min | ||
| INFUSION | 1 mg / hr | 8 mg / hr | |||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Lorazepam (Ativan) - Conc: 50 mg / 50 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 1 min | 2 mg over 1 min | 2 mg over 1 min | ||
| INFUSION | 0.5 mg / hr | 5 mg / hr | |||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Lorazepam (Ativan) - Conc: 50 mg / 50 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Use Filter | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 1 min | 2 mg over 1 min | 2 mg over 1 min | ||
| INFUSION | 0.5 mg / hr | 5 mg / hr | |||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| LR - see IV Fluid Plain | |||||
| LR + KCl, KPO4 ( > 500 mL) - see IV Fluid w Lytes | |||||
| M | |||||
Magnesium Sulfate Birthplace & ED only - Conc: 4 g / 50 mL (0.08 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification, Don't give in SNF | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Magnesium Sulfate Birthplace & ED only - Conc: 40 g / 1000 mL (0.04 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification, Don't give in SNF | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.25 g / hr | 1 g / hr | 6 g / hr | ||
| Volume to be infused = 1000 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Magnesium Sulfate Non-Birthplace or ED - Conc: 1 g / 100 mL (0.01 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification, Don't give in SNF | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 202 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Magnesium Sulfate Non-Birthplace or ED - Conc: 2 g / 50 mL (0.04 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification, Don't give in SNF | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Magnesium Sulfate Non-Birthplace or ED - Conc: 3 g / 100 mL (0.03 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification, Don't give in SNF | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Magnesium Sulfate - Conc: 1 g / 100 mL (0.01 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification, Don't give in SNF | |||||
| Locations: SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Mannitol 20% - Conc: 100 g / 500 mL (0.2 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Use Filter | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 2 g / hr | 50 g / hr | |||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Maxipime - see cefepime | |||||
| Mefoxin - see cefOXitin | |||||
Meropenem - Conc: 500 mg / 50 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Meropenem - Conc: 1 g / 50 mL (0.02 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 17 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Meropenem - Conc: 2 g / 100 mL (0.02 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 15 mL / hr | 33.3 mL / hr | 200 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Methylpred(Solu-Med) - Variable conc: 2 - 8 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1 mg / kg / hr | 5.41 mg / kg / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Metoclopramide - Conc: 20 mg / 50 mL (0.4 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Metronidazole-Flagyl - Conc: 250 mg / 50 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 50 mL / hr | 55 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Metronidazole-Flagyl - Conc: 500 mg / 100 mL (5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Micafungin-Mycamine - Conc: 50 mg / 100 mL (0.5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Micafungin-Mycamine - Conc: 100 mg / 100 mL (1 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Micafungin-Mycamine - Conc: 150 mg / 100 mL (1.5 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Midazolam (Versed) CC&ED Extended HM - Conc: 50 mg / 50 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 3 min | 1 mg over 3 min | 1.25 mg over 3 min | ||
| INFUSION | 0.5 mg / hr | 7 mg / hr | 40 mg / hr | ||
| midazolam is a "Care Area Critical Med": Hard MAX = 40 mg/hr Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Midazolam (Versed) CC&ED Extended HM - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mg / hr | 2 mg / hr | 7 mg / hr | 40 mg / hr | |
| midazolam is a "Care Area Critical Med": Hard MAX = 40 mg/hr Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Midazolam (Versed) CC&ED Low Max Infus. - Conc: 50 mg / 50 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.5 mg over 3 min | 1 mg over 3 min | 1.25 mg over 3 min | ||
| INFUSION | 0.5 mg / hr | 7 mg / hr | 10 mg / hr | ||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Midazolam (Versed) CC&ED Low Max Infus. - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mg / hr | 7 mg / hr | 10 mg / hr | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Midazolam ED - Conc: 50 mg / 60 mL (0.833 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 0.5 mg over 1 min | 1 mg over 5 min | 1.25 mg over 5 min | ||
| INFUSION | 0.5 mg / hr | 7 mg / hr | 10 mg / hr | ||
| Volume to be infused = 60 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Midazolam ED - Variable conc: 0.5 - 0.85 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.12 mg over 1 min | 1 mg over 5 min | 1.25 mg over 5 min | ||
| INFUSION | 0.5 mg / hr | 7 mg / hr | 10 mg / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
MILrinone - Conc: 20 mg / 100 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Do not titrate on 2North | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.125 mcg / kg / min | 0.87 mcg / kg / min | 2 mcg / kg / min | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Morphine - Conc: 30 mg / 60 mL (0.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.25 mg over 1 min | 1 mg over 1 min | |||
| LOAD | 0.25 mg over 1 min | 1 mg over 1 min | |||
| INFUSION | 0.25 mg / hr | 5 mg / hr | |||
| Volume to be infused = 60 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Morphine - Conc: 30 mg / 60 mL (0.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.25 mg over 1 min | 1 mg over 1 min | |||
| LOAD | 0.25 mg over 1 min | 1 mg over 1 min | |||
| INFUSION | 0.25 mg / hr | 5 mg / hr | |||
| Volume to be infused = 60 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Moxifloxacin(Avelox) - Conc: 400 mg / 250 mL (1.6 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 250 mL / hr | 255 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| N | |||||
| Nafcillin (Nafcil) - Conc: 1 g / 50 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Nafcillin (Nafcil) - Conc: 2 g / 100 mL (0.02 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Naloxone RespDe - Conc: 2 mg / 500 mL (0.004 mg / mL) ✅ | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 250 mL / hr | |||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Naloxone RespDe - Conc: 4 mg / 100 mL (0.04 mg / mL) | |||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 250 mL / hr | |||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Neo-Synephrine - see phenylephrine | |||||
NICARdipine - Conc: 25 mg / 250 mL (0.1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mg / hr | 5 mg / hr | 15 mg / hr | 15 mg / hr | |
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Nimbex - see CISatracurium | |||||
NitroGLYcerin - Conc: 50 mg / 250 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1.67 mcg / min | 5 mcg / min | 100 mcg / min | 200 mcg / min | |
| Volume to be infused = 250 mL, primary only, (KVO rate = 1 mL/hr) | |||||
NitroGLYcerin - Conc: 50 mg / 250 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 1.67 mcg / min | 5 mcg / min | 100 mcg / min | 200 mcg / min | |
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
NitroPRUSSide - Conc: 50 mg / 250 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.1 mcg / kg / min | 4 mcg / kg / min | 10 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 1 mL/hr) | |||||
NitroPRUSSide - Conc: 50 mg / 250 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.1 mcg / kg / min | 4 mcg / kg / min | 10 mcg / kg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Norcuron - see vecuronium | |||||
Norepinephrine Double Concentration - Conc: 8 mg / 250 mL (0.032 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.3 mcg / min | 2 mcg / min | 40 mcg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 1 mL/hr) | |||||
Norepinephrine Double Concentration - Conc: 8 mg / 250 mL (0.032 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.3 mcg / min | 2 mcg / min | 40 mcg / min | 250 mcg / min | |
| norEPINEPHrine is a "Care Area Critical Med": Hard MAX = 250 mcg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Norepinephrine Single Concentration - Conc: 4 mg / 250 mL (0.016 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / min | 2 mcg / min | 40 mcg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 1 mL/hr) | |||||
Norepinephrine Single Concentration - Conc: 4 mg / 250 mL (0.016 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / min | 2 mcg / min | 40 mcg / min | 250 mcg / min | |
| norEPINEPHrine is a "Care Area Critical Med": Hard MAX = 250 mcg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Normal Saline, NS - see IV Fluid Plain | |||||
| Normal Saline, NS + KCl, KPO4 ( > 500 mL) - see IV Fluid w Lytes | |||||
| Normal Saline, NS + KPO4 ( ≤ 500 mL) - see Potassium Phosphate | |||||
| Normal Saline, NS + NaPO4 - see Sodium Phosphate | |||||
| Nulojix - see belatacept | |||||
| O | |||||
Octreotide - Conc: 1000 mcg / 1000 mL (1 mcg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 1 mcg over 1 min | 16.6 mcg over 3 min | 17 mcg over 3 min | ||
| INFUSION | 25 mcg / hr | 50 mcg / hr | 250 mcg / hr | ||
| Volume to be infused = 1000 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Ondansetron (Zofran) - Variable conc: 0.2 - 0.64 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Orencia - see abatacept | |||||
Oxaliplatin - Variable conc: 0.02 - 0.2 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 200 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Oxytocin (Pitocin) Induction - Conc: 30 Units / 500 mL (0.06 Units / mL) | |||||
| Locations: BP | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 1 Units over 5 min | 11 Units over 30 min | |||
| INFUSION | 1 mUnits / min | 30 mUnits / min | |||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Oxytocin (Pitocin) Postpartum - mL mode ⟮ ⟯ ✅ |
|||||
| Locations: BP | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 150 mL / hr | 1000 mL / hr | ||
| Volume to be infused = 1000 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| P | |||||
Paclitaxel (Taxol) Dose ≤ 290mg - Variable conc: 0.04 - 1.16 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: USE NTG/FILTER SETS. USE LOW SORBING TUBING. | |||||
| Locations: | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 83.3 mL / hr | |||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Paclitaxel (Taxol) Dose > 290mg - Variable conc: 0.5 - 1.16 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: USE NTG/FILTER SETS. USE LOW SORBING TUBING. | |||||
| Locations: | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 167 mL / hr | 167 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Pamidronate (Aredia) - Conc: 30 mg / 500 mL (0.06 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 125 mL / hr | 125 mL / hr | ||
| Volume to be infused = 500 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Pamidronate (Aredia) - Conc: 60 mg / 500 mL (0.12 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 125 mL / hr | 125 mL / hr | ||
| Volume to be infused = 500 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Pamidronate (Aredia) - Conc: 90 mg / 500 mL (0.18 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 125 mL / hr | 125 mL / hr | ||
| Volume to be infused = 500 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Pantoprazole - Conc: 40 mg / 100 mL (0.4 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 4 mg / hr | 8 mg / hr | |||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Paraplatin - see CARBOplatin | |||||
| Pembrolizumab - Variable conc: 1 - 10 mg / mL ❌ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| Penicillin GK - Conc: 2.5 MillionUnits / 50 mL (0.05 MillionUnits / mL) ✅ | |||||
| Locations: 2N (TELE), BP, CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 110 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Penicillin GK - Conc: 5 MillionUnits / 100 mL (0.05 MillionUnits / mL) ✅ | |||||
| Locations: 2N (TELE), BP, CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Pentamidine - Variable conc: 1 - 2.5 mg / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 250 mL / hr | 255 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Pepcid - see famotidine | |||||
Phenylephrine Double Concentration - Conc: 100 mg / 250 mL (0.4 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED, IPN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mcg / min | 50 mcg / min | 450 mcg / min | 730 mcg / min | |
| phenylephrine is a "Care Area Critical Med": Hard MAX = 730 mcg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Phenylephrine Single Concentration - Conc: 10 mg / 100 mL (0.1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED, IPN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mcg / min | 50 mcg / min | 450 mcg / min | 730 mcg / min | |
| phenylephrine is a "Care Area Critical Med": Hard MAX = 730 mcg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Phenylephrine Single Concentration - Conc: 50 mg / 250 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED, IPN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mcg / min | 50 mcg / min | 450 mcg / min | 730 mcg / min | |
| phenylephrine is a "Care Area Critical Med": Hard MAX = 730 mcg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Phenylephrine - Conc: 10 mg / 100 mL (0.1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mcg / min | 50 mcg / min | 450 mcg / min | 730 mcg / min | |
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 1 mL/hr) | |||||
Phenylephrine - Conc: 50 mg / 250 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mcg / min | 50 mcg / min | 450 mcg / min | 730 mcg / min | |
| Volume to be infused = 250 mL, primary only, (KVO rate = 1 mL/hr) | |||||
Phenylephrine - Conc: 100 mg / 250 mL (0.4 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mcg / min | 50 mcg / min | 450 mcg / min | 730 mcg / min | |
| Volume to be infused = 250 mL, primary only, (KVO rate = 1 mL/hr) | |||||
Phenytoin (Dilantin) - Variable conc: 5 - 10 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 150 mL / hr | 300 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Phenytoin Peds - Variable conc: 5 - 10 mg / mL ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Use Filter | |||||
| Locations: PED ≤ 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.1 mcg / kg / min | 2.5 mcg / kg / min | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Phytonadione (Vit K) - Conc: 5 mg / 50 mL (0.1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Phytonadione (Vit K) - Conc: 10 mg / 50 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Piperacillin/tazobac - Conc: 3.375 g / 50 mL (0.068 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 5 mL / hr | 12.5 mL / hr | 105 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Piperacillin/tazobac - Conc: 4.5 g / 100 mL (0.045 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 20 mL / hr | 25 mL / hr | 200 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Pitocin - see oxytocin | |||||
| Pitressin - see vasopressin | |||||
| Platelets - see Blood Platelets | |||||
| Platinol - see CISplatin | |||||
| Potassium Chloride Rider - see KCL Rider | |||||
Potassium Phosphate Central Line - Conc: 15 mmol / 100 mL (0.15 mmol / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 20 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Potassium Phosphate Central Line - Conc: 30 mmol / 250 mL (0.12 mmol / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 31.3 mL / hr | 41.7 mL / hr | 62.5 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Potassium Phosphate Peripheral Line - Conc: 15 mmol / 250 mL (0.06 mmol / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 41.6 mL / hr | 41.6 mL / hr | 62.5 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Potassium Phosphate Peripheral Line - Conc: 30 mmol / 500 mL (0.06 mmol / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 62.5 mL / hr | 62.5 mL / hr | 62.5 mL / hr | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Potassium Phosphate - Conc: 15 mmol / 250 mL (0.06 mmol / mL) ⟮ ⟯ ✅ |
|||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 41.6 mL / hr | 41.6 mL / hr | 62.5 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Potassium Phosphate - Conc: 30 mmol / 500 mL (0.06 mmol / mL) ⟮ ⟯ ✅ |
|||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 62.5 mL / hr | 62.5 mL / hr | 62.5 mL / hr | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Potassium Phosphate ( > 500 mL) - see IV Fluid w Lytes | |||||
| Precedex - see dexmedetomidine | |||||
| Primacor - see milrinone | |||||
| Primaxin - see imipenem/cilastatin | |||||
Procainamide Loading Dose - Conc: 1000 mg / 50 mL (20 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mg / min | 50 mg / min | |||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Procainamide Maintenance Dose - Conc: 1000 mg / 250 mL (4 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mg / min | 1 mg / min | 4 mg / min | ||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Propofol (Diprivan) CC&ED Extended HM - Conc: 500 mg / 50 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED, IPN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 5 mg over 10 sec | 100 mg over 60 sec | |||
| LOAD | 5 mg over 10 sec | 100 mg over 60 sec | |||
| INFUSION | 0.2 mcg / kg / min | 5 mcg / kg / min | 50 mcg / kg / min | 80 mcg / kg / min | |
| propofol is a "Care Area Critical Med": Hard MAX = 80 mcg/kg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Propofol (Diprivan) CC&ED Extended HM - Conc: 1000 mg / 100 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED, IPN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 5 mg over 10 sec | 200 mg over 60 sec | |||
| LOAD | 5 mg over 10 sec | 200 mg over 60 sec | |||
| INFUSION | 0.5 mcg / kg / min | 5 mcg / kg / min | 50 mcg / kg / min | 80 mcg / kg / min | |
| propofol is a "Care Area Critical Med": Hard MAX = 80 mcg/kg/min Two licensed personnel MUST independently verify the pump settings for the use of these Hard MAX settings. Guidelines |
|||||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Propofol (Diprivan) CC&ED Low Max Infus. - Conc: 500 mg / 50 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED, IPN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.2 mcg / kg / min | 5 mcg / kg / min | 50 mcg / kg / min | ||
| Volume to be infused = 50 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Propofol (Diprivan) CC&ED Low Max Infus. - Conc: 1000 mg / 100 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED, IPN | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.5 mcg / kg / min | 5 mcg / kg / min | 50 mcg / kg / min | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Propofol (Diprivan) - Conc: 500 mg / 50 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 5 mg over 10 sec | 100 mg over 60 sec | |||
| LOAD | 5 mg over 10 sec | 100 mg over 60 sec | |||
| INFUSION | 0.2 mcg / kg / min | 5 mcg / kg / min | 50 mcg / kg / min | 80 mcg / kg / min | |
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 1 mL/hr) | |||||
Propofol (Diprivan) - Conc: 1000 mg / 100 mL (10 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 5 mg over 10 sec | 100 mg over 60 sec | |||
| LOAD | 5 mg over 10 sec | 100 mg over 60 sec | |||
| INFUSION | 0.5 mcg / kg / min | 5 mcg / kg / min | 50 mcg / kg / min | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Protamine - Conc: 50 mg / 50 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 300 mL / hr | 300 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| prothrombin complex - see Kcentra | |||||
| Protonix - see pantoprazole | |||||
| R | |||||
| Rally Bag - mL mode ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 125 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Volume to be infused = 1000 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Rasburicase - Variable conc: 0.02 - 0.15 mg / mL ✅ | |||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| RBC - see Blood RBC | |||||
| Reclast - see zoledronic acid | |||||
| Reglan - see metoclopramide | |||||
| Remdesivir - Conc: 100 mg / 250 mL (0.4 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 500 mL / hr | 500 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Remdesivir - Conc: 200 mg / 250 mL (0.8 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 250 mL / hr | 500 mL / hr | 500 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Rifampin - Conc: 600 mg / 100 mL (6 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Rituximab - Variable conc: 1 - 4 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 20 mL / hr | 300 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Rocephin - see cefTRIAXone | |||||
Rocuronium (Zemuron) - Conc: 200 mg / 100 mL (2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.4 mg / kg over 5 min | 1 mg / kg over 5 min | |||
| INFUSION | 1 mcg / kg / min | 8 mcg / kg / min | 12 mcg / kg / min | 16 mcg / kg / min | |
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| S | |||||
| SandIMMUNE - see cycloSPORINE | |||||
| SandoSTATIN - see octreotide | |||||
Sarilumab (Kevzara) - Conc: 400 mg / 100 mL (4 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 105 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| SMZ-TMP - see Bactrim | |||||
| Sodium Bicarbonate - Variable conc: 0.05 - 0.15 mEq / mL ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 1000 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Sodium Chloride 0.9% - see IV Fluid Plain | |||||
Sodium Chloride 3% - Conc: 15 g / 500 mL (0.03 g / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual Clinician Verification, (Not for use in SNF) | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 3.3 mL / hr | 30 mL / hr | 100 mL / hr | 100 mL / hr | |
| Volume to be infused = 500 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Sodium Phosphate - Variable conc: 0.04 - 0.18 mmol / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 30 mL / hr | 62.5 mL / hr | 62.5 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Sodium Phosphate - Variable conc: 0.04 - 0.18 mmol / mL ⟮ ⟯ ✅ |
|||||
| Locations: Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 30 mL / hr | 62.5 mL / hr | 62.5 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Sodium Thiosulfate - Conc: 12.5 g / 50 mL (0.25 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 100 mL / hr | 300 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Solu-MEDROL - see methylPREDNISolone | |||||
| Synthroid - see levothyroxine | |||||
| T | |||||
| Taxol - see PACLitaxel | |||||
| Taxotere - see DOCEtaxel | |||||
| Teflaro - see ceftaroline | |||||
| Thiamine IVPB - Conc: 50 mg / 50 mL (1 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Thiamine+Folic Acid - Conc: 101 mg / 100 mL (1.01 mg / mL) ❌ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Tigecycline - Conc: 50 mg / 100 mL (0.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Tigecycline - Conc: 100 mg / 100 mL (1 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 210 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Tirofiban - Conc: 5 mg / 100 mL (0.05 mg / mL) ⟮ ⟯ ✅ |
|||||
| Advisory: Dual RN Verification, Load 5 mcg/kg/min x 5 minutes = 25 mcg/kg total load | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 10 mcg / kg over 5 min | 25 mcg / kg over 5 min | 25.1 mcg / kg over 5 min | ||
| INFUSION | 0.05 mcg / kg / min | 0.15 mcg / kg / min | 0.15 mcg / kg / min | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Tirofiban - Conc: 12.5 mg / 250 mL (0.05 mg / mL) | |||||
| Advisory: Dual RN Verification, Load 5 mcg/kg/min x 5 minutes = 25 mcg/kg total load | |||||
| Locations: 2N (TELE), CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| LOAD | 10 mcg / kg over 5 min | 25 mcg / kg over 5 min | 25.1 mcg / kg over 5 min | ||
| INFUSION | 0.05 mcg / kg / min | 0.15 mcg / kg / min | |||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Tobramycin - Variable conc: 0.6 - 10 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Tocilizumab(Actemra) - Variable conc: 0.1 - 8 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 20 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| tPA - see alteplase | |||||
| TPN - see Clinimix TPN | |||||
| Trandate - see labetalol | |||||
| Tranexamic Acid IVPB - Conc: 1000 mg / 50 mL (20 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 100 mL / hr | 100 mL / hr | ||
| Volume to be infused = 50 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Tranexamic Acid IVPB - Conc: 1000 mg / 100 mL (10 mg / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 150 mL / hr | 200 mL / hr | 220 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Trastuzumab Loading Dose - Variable conc: 0.12 - 1.68 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 167 mL / hr | 168 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
Trastuzumab Maintenance Dose - Variable conc: 0.12 - 1.68 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 500 mL / hr | 500 mL / hr | ||
| Undefined volume to be infused, primary only, (KVO rate = 10 mL/hr) | |||||
| TXA - see Tranexamic Acid | |||||
| U | |||||
| Unasyn - see ampicillin-sulbactam | |||||
| V | |||||
Valproic Acid - Variable conc: 0.4 - 20 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mL / hr | 50 mL / hr | 50 mL / hr | ||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Vancomycin Infusion over 1 hr - Conc: 500 mg / 100 mL (5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 20 mL / hr | 100 mL / hr | 101 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Vancomycin Infusion over 1 hr - Conc: 750 mg / 100 mL (7.5 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 100 mL / hr | 101 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Vancomycin Infusion over 1 hr - Conc: 1 g / 200 mL (0.005 g / mL) ✅ | |||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 200 mL / hr | 200 mL / hr | ||
| Volume to be infused = 200 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Vancomycin Infusion over 1 hr - Conc: 1 g / 250 mL (0.004 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Vancomycin Infusion over 1 hr - Conc: 1.25 g / 250 mL (0.005 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Vancomycin Infusion over 2 hrs - Conc: 1.5 g / 250 mL (0.006 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 125 mL / hr | 125 mL / hr | ||
| Volume to be infused = 250 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Vancomycin Infusion over 2 hrs - Conc: 1.75 g / 500 mL (0.004 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Vancomycin Infusion over 2 hrs - Conc: 2 g / 500 mL (0.004 g / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 250 mL / hr | 250 mL / hr | ||
| Volume to be infused = 500 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Vancomycin Peds - Variable conc: 0.5 - 5 g / mL ✅ | |||||
| Advisory: Dual RN Verification | |||||
| Locations: PED ≤ 20 kg, Ped > 20 kg | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 10 mg / kg / hr | 23 mg / kg / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
VASOpressin Vasopressin GI - Conc: 100 Units / 250 mL (0.4 Units / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.1 Units / min | 0.9 Units / min | |||
| Volume to be infused = 250 mL, primary only, (KVO rate = 10 mL/hr) | |||||
VASOpressin Vasopressin Shock - Conc: 20 Units / 100 mL (0.2 Units / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 0.01 Units / min | 0.04 Units / min | |||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
Vecuronium(Norcuron) - Conc: 20 mg / 100 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ANES | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.05 mg / kg over 1 min | 0.1 mg / kg over 1 min | |||
| INFUSION | 0.1 mcg / kg / min | 1.2 mcg / kg / min | 2 mcg / kg / min | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 1 mL/hr) | |||||
Vecuronium(Norcuron) - Conc: 20 mg / 100 mL (0.2 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU, ED | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| BOLUS | 0.05 mg / kg over 5 min | 0.1 mg / kg over 5 min | |||
| INFUSION | 0.1 mcg / kg / min | 1.2 mcg / kg / min | 2 mcg / kg / min | ||
| Volume to be infused = 100 mL, primary only, (KVO rate = 10 mL/hr) | |||||
| Veklury - see remdesivir | |||||
| Vepesid - see etoposide | |||||
| Versed - see midazolam | |||||
| Vfend - see voriconazole | |||||
| Vibramycin - see doxycycline | |||||
| Vimpat - see lacosamide | |||||
| Vistide - see cidofovir | |||||
| Vitamin K - see phytonadione | |||||
Voriconazole - Variable conc: 0.5 - 5 mg / mL ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, CCU, ED, ICS/Oncology, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 25 mL / hr | 125 mL / hr | |||
| Undefined volume to be infused, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Vyepti - see eptinezumab | |||||
| Z | |||||
| Zemuron - see rocuronium | |||||
| Zerbaxa - see ceftolozane-tazobactam | |||||
| Zinacef - see cefuroxime | |||||
| Zithromax - see azithromycin | |||||
| Zofran - see ondansetron | |||||
Zoledronic acid - Conc: 4 mg / 100 mL (0.04 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: 1N, 2N (TELE), 3N, 5N, BP, ED, SNF | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 400 mL / hr | 400 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Zoledronic acid - Conc: 4 mg / 100 mL (0.04 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: CCU | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 400 mL / hr | 400 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Zoledronic acid - Conc: 4 mg / 100 mL (0.04 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 400 mL / hr | 400 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Zoledronic acid - Conc: 4 mg / 100 mL (0.04 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 100 mL / hr | 400 mL / hr | 400 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Zoledronic acid - Conc: 5 mg / 100 mL (0.05 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: ICS/Oncology | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 400 mL / hr | 400 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
Zoledronic acid - Conc: 5 mg / 100 mL (0.05 mg / mL) ⟮ ⟯ ✅ |
|||||
| Locations: | |||||
| Type | Hard MIN | Soft MIN | Normal Start Rate | Soft MAX | Hard MAX |
| INFUSION | 50 mL / hr | 400 mL / hr | 400 mL / hr | ||
| Volume to be infused = 100 mL, primary or secondary, (KVO rate = 10 mL/hr) | |||||
| Zometa - see zoledronic acid | |||||
| Zosyn - see piperacillin-tazobactam | |||||
| Zovirax - see acyclovir | |||||
| Zyvox - see linezolid | |||||
| END | |||||